---
figid: PMC4589126__btt-9-093Fig1
figtitle: Clinical utility of ramucirumab in advanced gastric cancer
organisms:
- Homo sapiens
- Mus musculus
- Iris germanica
organisms_ner:
- Mus musculus
- Homo sapiens
pmcid: PMC4589126
filename: btt-9-093Fig1.jpg
figlink: /pmc/articles/PMC4589126/figure/f1-btt-9-093/
number: F1
caption: 'Strategies to inhibit VEGF pathway signaling.Notes: (A) anti-VEGF antibody
  (eg, bevacizumab); (B) anti-VEGFR-2 antibody (eg, ramucirumab); (C) soluble VEGF
  receptors (eg, aflibercept); and (D) VEGF receptor tyrosine kinase inhibitors (eg,
  sunitinib, sorafenib, regorafenib, apatinib [anti-VEGFR-2 TKI]).Abbreviations: Ab,
  antibody; TKI, tyrosine kinase inhibitor; VEGF, vascular endothelial growth factor;
  VEGFR, vascular endothelial growth factor receptor.'
papertitle: Clinical utility of ramucirumab in advanced gastric cancer.
reftext: Matthew MK Chan, et al. Biologics. 2015;9:93-105.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8851274
figid_alias: PMC4589126__F1
figtype: Figure
redirect_from: /figures/PMC4589126__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4589126__btt-9-093Fig1.html
  '@type': Dataset
  description: 'Strategies to inhibit VEGF pathway signaling.Notes: (A) anti-VEGF
    antibody (eg, bevacizumab); (B) anti-VEGFR-2 antibody (eg, ramucirumab); (C) soluble
    VEGF receptors (eg, aflibercept); and (D) VEGF receptor tyrosine kinase inhibitors
    (eg, sunitinib, sorafenib, regorafenib, apatinib [anti-VEGFR-2 TKI]).Abbreviations:
    Ab, antibody; TKI, tyrosine kinase inhibitor; VEGF, vascular endothelial growth
    factor; VEGFR, vascular endothelial growth factor receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Vegfa
  - App
  - H2-Ab1
  - Flt1
  - Kdr
  - Flt4
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - APP
  - SUCLA2
  - FLT1
  - KDR
  - FLT4
---
